Publikationen von Martin E. Keck

Kopf-Beck, J.; Müller, C.; Tamm, J.; Fietz, J.; Rek, N.; Just, L.; Spock, Z. I.; Weweck, K.; Takano, K.; Rein, M. et al.; Keck, M. E.; Egli, S.: Effectiveness of Schema Therapy versus Cognitive Behavioral Therapy versus Supportive Therapy for Depression in Inpatient and Day Clinic Settings: A Randomized Clinical Trial. PSYCHOTHERAPY AND PSYCHOSOMATICS 93 (1), S. 24 - 35 (2024)

Dimitrov, A.; Veer, I. M.; Kleeblatt, J.; Seyfarth, F.; Roenneberg, T.; Ising, M.; Uhr, M.; Keck, M.; Kramer, A.; Berger, M. et al.; von Koch, L.; Walter, H.; Adli, M.: Chronotype is associated with psychological well-being depending on the composition of the study sample. JOURNAL OF HEALTH PSYCHOLOGY 25 (9), S. 1236 - 1247 (2020)

Kappelmann, N.; Rein, M.; Fietz, J.; Mayberg, H. S.; Craighead, W. E.; Dunlop, B. W.; Nemeroff, C. B.; Keller, M.; Klein, D. N.; Arnow, B. A. et al.; Husain, N.; Jarrett, R. B.; Vittengl, J. R.; Menchetti, M.; Parker, G.; Barber, J. P.; Bastos, A. G.; Dekker, J.; Peen, J.; Keck, M. E.; Kopf-Beck, J.: Psychotherapy or medication for depression? Using individual symptom meta-analyses to derive a Symptom-Oriented Therapy (SOrT) metric for a personalised psychiatry. BMC MEDICINE 18 (1), 170 (2020)

Brückl, T. M.; Spoormaker, V. I.; Sämann, P. G.; Brem, A.-K.; Henco, L.; Czamara, D.; Elbau, I.; Grandi, N. C.; Jollans, L.; Kühnel, A. et al.; Leuchs, L.; Pöhlchen, D.; Schneider, M.; Tontsch, A.; Keck, M. E.; Schilbach, L.; Czisch, M.; Lucae, S.; Erhardt, A.; Binder, E. B.: The biological classification of mental disorders (BeCOME) study: a protocol for an observational deep-phenotyping study for the identification of biological subtypes. BMC PSYCHIATRY 20 (1), 213 (2020)

Kopf-Beck, J.; Zimmermann, P.; Egli, S.; Rein, M.; Kappelmann, N.; Fietz, J.; Tamm, J.; Rek, K.; Lucae, S.; Brem, A.-K. et al.; Saemann, P.; Schilbach, L.; Keck, M. E.: Schema therapy versus cognitive behavioral therapy versus individual supportive therapy for depression in an inpatient and day clinic setting: study protocol of the OPTIMA-RCT. BMC PSYCHIATRY 20 (1), 506 (2020)

Kappelmann, N.; Kopf-Beck, J.; Khandaker, G. M.; Keck, M. E.: Deciphering polygenic risk for inflammation and depressive symptoms: a network analysis approach. EUROPEAN NEUROPSYCHOPHARMACOLOGY 29, S. S16 - S16 (2019)

Keck, M. E.; Kappelmann, N.; Kopf-Beck, J.: Translational research as prerequisite for personalized psychiatry. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 268 (3), S. 215 - 217 (2018)

Pawlowski, M. A.; Gazea, M.; Wollweber, B.; Dresler, M.; Holsboer, F.; Keck, M. E.; Steiger, A.; Adamczyk, M.; Mikoteit, T.: Heart rate variability and cordance in rapid eye movement sleep as biomarkers of depression and treatment response. Journal of psychiatric research 92, S. 64 - 73 (2017)

Palm, U.; Musil, R.; Ienciu, M.; Jakovljevic, M.; Kapfhammer, H.-P.; Kasper, S.; Keck, M. E.; Langguth, B.; Lanzenberger, R.; Meisenzahl, E. et al.; Moeller, H.-J.; Mueller, N.; Nedopil, N.; Sartorius, N.; Schoeny, W.; Falkai, P.: THE 26TH Danube Symposium of Psychiatry: Psychiatry - Ready for the Future? [Letter to Editor]. PSYCHIATRIA DANUBINA 28 (1), S. 95 - 96 (2016)

Stamm, T. J.; Rampp, C.; Wiethoff, K.; Stingl, J.; Moessner, R.; O'Malley, G.; Ricken, R.; Seemueller, F.; Keck, M.; Fisher, R. et al.; Gaebel, W.; Maier, W.; Moeller, H.-J.; Bauer, M.; Adli, M.: The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depression. JOURNAL OF PSYCHOPHARMACOLOGY 30 (1), S. 40 - 47 (2016)

Schmidt, U.; Keck, M.; Buell, D. R.: miRNAs and other non-coding RNAs in posttraumatic stress disorder: A systematic review of clinical and animal studies. JOURNAL OF PSYCHIATRIC RESEARCH 65, S. 1 - 8 (2015)

Wollweber, B.; Keck, M. E.; Schmidt, U.: Improvement of nonsuicidal self-injury following treatment with antipsychotics possessing strong D1 antagonistic activity: evidence from a report of three cases. Therapeutic advances in psychopharmacology 5 (4), S. 208 - 13 (2015)

Erhardt, A.; Czibere, L.; Roeske, D.; Lucae, S.; Unschuld, P. G.; Ripke, S.; Specht, M.; Kohli, M. A.; Kloiber, S.; Ising, M. et al.; Heck, A.; Pfister, H.; Zimmermann, P.; Lieb, R.; Pütz, B.; Uhr, M.; Weber, P.; Deussing, J. M.; Gonik, M.; Bunck, M.; Kessler, M. S.; Frank, E.; Hohoff, C.; Domschke, K.; Krakowitzky, P.; Maier, W.; Bandelow, B.; Jacob, C.; Deckert, J.; Schreiber, S.; Strohmaier, J.; Nöthen, M.; Cichon, S.; Rietschel, M.; Bettecken, T.; Keck, M. E.; Landgraf, R.; Müller-Myhsok, B.; Holsboer, F.; Binder, E. B.: TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Molecular Psychiatry 16 (6), S. 647 - 663 (2011)

Hohoff, C.; Mullings, E. L.; Heatherley, S. V.; Freitag, C. M.; Neumann, L. C.; Domschke, K.; Krakowitzky, P.; Rothermundt, M.; Keck, M. E.; Erhardt, A. et al.; Unschuld, P. G.; Jacob, C.; Fritze, J.; Bandelow, B.; Maier, W.; Holsboer, F.; Rogers, P. J.; Deckert, J.: Adenosine A(2A) receptor gene: Evidence for association of risk variants with panic disorder and anxious personality. Journal of Psychiatric Research 44 (14), S. 930 - 937 (2010)

Thoeringer, C. K.; Erhardt, A.; Sillaber, I.; Mueller, M. B.; Ohl, F.; Holsboer, F.; Keck, M. E.: Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice. Journal of Psychopharmacology 24 (5), S. 733 - 743 (2010)

Amador-Arjona, A.; Delgado-Morales, R.; Belda, X.; Gagliano, H.; Gallego, X.; Keck, M. E.; Armario, A.; Dierssen, M.: Susceptibility to stress in transgenic mice overexpressing TrkC, a model of panic disorder. Journal of Psychiatric Research 44 (3), S. 157 - 167 (2010)

Thoeringer, C. K.; Ripke, S.; Unschuld, P. G.; Lucae, S.; Ising, M.; Bettecken, T.; Uhr, M.; Keck, M. E.; Mueller-Myhsok, B.; Holsboer, F. et al.; Binder, E. B.; Erhardt, A.: The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders. Journal of Neural Transmission 116 (6), S. 649 - 657 (2009)

Erhardt, A.; Müller, M. B.; Rödel, A.; Welt, T.; Ohl, F.; Holsboer, F.; Keck, M. E.: Consequences of chronic social stress on behaviour and vasopressin gene expression in the PVN of DBA/2OlaHsd mice-influence of treatment with the CRHR1-antagonist R121919/NBI 30775. Journal of Psychopharmacology 23 (1), S. 31 - 39 (2009)

Keck, M. E.; Kern, N.; Erhardt, A.; Unschuld, P. G.; Ising, M.; Salyakina, D.; Müller, M. B.; Knorr, C. C.; Lieb, R.; Hohoff, C. et al.; Krakowitzky, P.; Maier, W.; Bandelow, B.; Fritze, J.; Deckert, J.; Holsboer, F.; Müller-Myhsok, B.; Binder, E. B.: Combined Effects of Exonic Polymorphisms in CRHR1 and AVPR1B Genes in a Case/Control Study for Panic Disorder. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 147B (7), S. 1196 - 1204 (2008)

Erhardt, A.; Lucae, S.; Kern, N.; Unschuld, P. G.; Ising, M.; Lieb, R.; Uhr, M.; Hohoff, C.; Deckert, J.; Bandelow, B. et al.; Maier, W.; Binder, E. B.; Müller-Myhsok, B.; Keck, M. E.; Holsboer, F.: Association of polymorphisms in the angiotensin-converting enzyme gene with syndromal panic attacks. Molecular Psychiatry 13 (3), S. 242 - 243 (2008)